Search Results
Keyword:STI
Institute of Genetics and Developmental Biology, CAS Develops TKO and "All-in-One" TRIM Genome Editing System, Achieving "One-Stop" Precise Pyramiding of Complex Crop Traits
In the process of modern agricultural crop breeding, although a large number of elite alleles have been successively sequenced and identified, how to rapidly and precisely pyramid them into a single variety has always faced the technical bottleneck of multi-generational crossbreeding and repeated experimental optimization. The research team at the Institute of Genetics and Developmental Biology, Chinese Academy of Sciences (CAS) has successfully tackled this challenge by developing a precise gene knockout tool TKO and an all-in-one composite genome editing system TRIM (Targeted Replacement, Insertion and Mutagenesis), opening up a new pathway for one-stop targeted improvement of complex agronomic traits. Targeting...
2026-09-24
China Institute of Atomic Energy Holds 2026 Science and Technology Innovation Conference, Releases Three Independently Developed Scientific and Technological Achievements: Industrial Software, Radiation-Resistant Robot, and Monitoring Watch
On September 23, China Institute of Atomic Energy (CIAE) of China National Nuclear Corporation (CNNC) officially convened the 2026 Science and Technology Innovation Conference, systematically planning and coordinating key tasks for nuclear basic research and original innovation. The conference brought together Sun Changpu, Ye Guoan, Liu Weiping, and Li Jun, academicians of the Chinese Academy of Sciences; Hu Shilin, Wang Hualin, and Su Guanghui, academicians of the Chinese Academy of Engineering; as well as representatives from research and industrial units including CNNC and Aerospace Software. Three independently developed innovative scientific and technological achievements were released on site: the Yundian Product Data Management System N-PDM, the Anluan-R Radiation-Resistant Inspection Robot, and the Antai-W1 Smart Radiation Monitoring Watch...
2026-09-24
Nova Fusion and Fuyao University of Science and Technology Jointly Established Fusion Innovation Research Institute and Innovation Laboratory Unveiled
On September 22, 2026, the Fuyao UST·Nova Fusion Innovation Research Institute and the Fuyao University of Science and Technology·Nova Fusion Innovation Laboratory were officially unveiled and established. Wang Shuguo, President of Fujian Fuyao University of Science and Technology, Guo Houyang, founder of Nova Fusion Energy Technology (Shanghai) Co., Ltd. (hereinafter referred to as "Nova Fusion"), and personnel from relevant departments including the Fujian Provincial Development and Reform Commission, Department of Education, Department of Science and Technology, and Department of Industry and Information Technology attended the unveiling ceremony. Zhang Fuli, Executive Vice President of Fuyao University of Science and Technology, presided over the ceremony. The Fuyao UST·Nova Fusion Innovation Research Institute and the Fuyao University of Science and Technology·Nova Fusion Innovation Laboratory established this time are jointly built by Fuyao UST and Nova Fusion, dedicated to promoting fusion energy technology from the laboratory to commercial application.
2026-09-23
Weilan Stellar Completes China's First Stellarator Magnet Cryogenic Comprehensive Test Platform in Three Months, First Round of Magnet Testing Launched
Weilan Stellar recently completed the construction of China's first stellarator magnet cryogenic comprehensive test platform, and the first round of magnet testing has been launched. Qiu Lilong, a review expert for the cryogenic system, stated that from independent design and system integration to domestically sourced supporting equipment, Weilan Stellar took only three and a half months to integrate vacuum, cryogenics, power supply, measurement, and protection into a comprehensive test platform. The test platform fully demonstrates the team's outstanding capabilities in scientific research, engineering, and project management. As the foundation for stable operation of a stellarator, the cryogenic system's vacuum level, sealing performance, and cooling capacity are all crucial. Unlike conventional paced R&D models, Weilan Stellar has always adhered to a pragmatic,...
2026-09-23
CNNC High Energy Seminar Focuses on Quality Control of Domestic Radiotherapy Equipment, Multiple Parties Join Hands to Build Industry Standards
On September 21, in order to further promote the construction of a quality control system for domestic radiotherapy equipment, standardize clinical quality control work for Tomo equipment, and facilitate multi-party collaborative development among industry, academia, research, and medical institutions, CNNC High Energy organized a seminar on quality control standardization for radiotherapy equipment. The meeting brought together industry forces from multiple sectors. Professor Zhang Fuquan, President of the Radiotherapy Equipment Technology Branch of the China Association of Medical Equipment and of Peking Union Medical College Hospital, and Professor Qiu Jie, Vice President of the Radiotherapy Equipment Technology Branch of the China Association of Medical Equipment and of Peking Union Medical College Hospital, attended the meeting as clinical experts; management, technical, and business representatives from CNNC High Energy, CNNC Accuray, Shuimu Medical, Shuimu Lingrui, and other units attended the meeting together. At the meeting, with...
2026-09-22
Guoke Ion Makes Its Debut at AOCMP 2026, Domestic Ion Therapy Technology Draws Attention from Asia-Pacific Peers
From September 9 to 11, 2026, the 26th Asia-Oceania Congress of Medical Physics (AOCMP 2026) was held at the Busan Port International Exhibition & Convention Center (BPEX) in South Korea. Hosted by the Korean Society of Medical Physics (KSMP), this year's congress focused on innovative applications of cutting-edge technologies such as artificial intelligence and automation in the field of medical physics, and is a highly influential academic event in the Asia-Pacific region. Wang Xiaomin, Deputy General Manager of Guoke Ion, and Yang Wenjie, Assistant to the General Manager, led a delegation to attend the congress, actively carrying out academic exchanges and industry engagement. During the congress, the Guoke Ion team conducted technical presentations and exchanges through specialized seminars and a corporate exhibition booth. At the specialized seminar, the team systematically introduced the company's ion therapy equipment and its self-developed...
2026-09-22
Nuclear energy startup Hylenr completes Phase 1 testing of lattice confinement fusion reactor validation study
Hylenr Inc., a nuclear energy startup based in Michigan, USA, recently completed Phase 1 testing of an independent validation study of its Lattice Confinement Fusion (LCF) reactor at Texas A&M University. Experimental results showed anomalous signals in areas including heat, gas, and materials, and Hylenr stated that the data indicate the technology warrants further in-depth investigation. Basic test information: In a strictly controlled laboratory environment, researchers conducted tests on Hylenr's BRT-NiUCS-2 reactor and multiple hydrogen-absorbing nickel-palladium catalyst samples, focusing on monitoring post-test heat, radiation, residual gases, and...
2026-09-22
Jiluntai's independently developed HER2-targeted diagnostic new drug has been approved for clinical trials, expected to facilitate precision treatment of breast cancer
Jiluntai Company, a nuclear medicine innovation enterprise invested and incubated by Baiyang Pharmaceutical Group, has recently made important progress. Its independently developed Class 1 chemical radioactive diagnostic new drug —— Technetium [⁹⁹ᵐTc] hydrazinonicotinamide dual-chain Ark peptide injection (⁹⁹ᵐTc‑HP‑Ark2), has received supplementary clinical trial application approval from the National Medical Products Administration (NMPA), which means the product will continue to undergo clinical trials, bringing new hope for precision subtyping and treatment of breast cancer. This product is a radioactive diagnostic agent for SPECT/CT imaging, intended for the differential diagnosis of HER2-positive breast cancer. HER2 is an important prognostic indicator for malignant tumors such as breast cancer...
2026-09-21
A delegation from Vietnam National University Ho Chi Minh City visited the Joint Institute for Nuclear Research to deepen cooperation in research and talent development
A working delegation from Vietnam National University Ho Chi Minh City recently visited the Joint Institute for Nuclear Research (JINR) in Dubna, Russian Federation, and held a working meeting. The two sides had in-depth exchanges of views on cooperation directions in talent cultivation, scientific research, and human resource development. In terms of talent cultivation and human resource development, the two sides discussed cooperation in fields such as nuclear physics, particle physics, heavy ion physics, quantum physics, advanced materials, nanotechnology, applied mathematics, radiation biology, and data science. Specific forms of cooperation include exchanging master's students, doctoral students, lecturers, and scientists, as well as jointly supervising doctoral students. Vietnam National University Ho Chi Minh City...
2026-09-20
Ningde Nuclear Power adopts AR maintenance solution, greatly boosting the efficiency of frontline operation and maintenance personnel
On September 9, at the production command center of Ningde Nuclear Power Plant, staff members only need to put on lightweight AR smart helmets and can obtain the required work information through voice commands. Equipment temperature and vibration data are automatically entered into the system, greatly shortening the time for inspection data entry. This AR smart helmet is an important benchmark project of Ningde Nuclear Power as a pilot enterprise for digital transformation under SASAC. It integrates information such as operation data, equipment drawings, work packages, and training materials, changing the traditional model in which nuclear power personnel rely on paper documents for on-site operations. This AR maintenance platform relies on technologies such as diffractive optical waveguides, 5G real-time transmission, and cross-system data interoperability, and integrates temperature measurement, vibration measurement...
2026-09-18
CNNC 404 Overcomes Krypton Isotope Technical Challenges, Multiple Krypton Isotope Thickness Sources Achieve "Fully Domestic Production"
It was learned from China National Nuclear Corporation (CNNC) that CNNC 404 Co., Ltd., a subsidiary of CNNC, has achieved a breakthrough in the field of radioisotope technology, marking China's leap from reliance on imports to fully domestic production of krypton isotope thickness sources. It is understood that krypton isotopes, as important radioisotopes, are widely used in industrial thickness measurement, instrument and meter calibration, tracer monitoring, and other fields, and are particularly indispensable in quality control for high-end manufacturing such as new energy batteries, specialty papermaking, and thin films. In this instance, CNNC 404 successfully developed multiple specifications of krypton isotope thickness source products with independent intellectual property rights, capable of matching the needs of different industrial thickness measurement application scenarios, which has provided solid support for the sustainable and high-quality development of China's high-end...
2026-09-17
DeVry University and Pulse Radiology Institute Partner to Launch Degree in Magnetic Resonance Imaging Technology
DeVry University and Pulse Radiology Institute (Pulse Radiology Institute) recently announced a partnership to jointly launch a new associate degree specialization in Magnetic Resonance Imaging (MRI) technology. This degree program innovatively combines DeVry University's flexible and convenient online theoretical courses with Pulse Radiology Institute's mature clinical training model and its network of college and healthcare partners across the United States. The core purpose of launching this hybrid training program is to address the staffing shortage crisis currently facing the healthcare industry. According to data published by the American Society of Radiologic Technologists (ASRT), the current vacancy rate for MRI technologists is as high as 1...
2026-09-16
Eagle Nuclear Energy Corp. Expands Government Affairs and Uranium Advisory Capabilities to Support the U.S. Domestic Nuclear Fuel Supply Chain
On September 9, Eagle Nuclear Energy Corp., a next-generation nuclear energy company that owns one of the largest measured and indicated conventional uranium deposits in the United States, announced in Reno, Nevada, that it has engaged LSN Partners (LSN) to provide government affairs, strategic advisory, and stakeholder communications services. The company also announced the appointment of Blake Steele as a strategic advisor. As a government affairs consulting firm, LSN will assist Eagle in advancing its public-sector development objectives at the federal and state levels. The collaboration will focus on U.S. domestic uranium production, advanced nuclear technology, critical minerals policy, energy...
2026-09-16
Westinghouse eVinci Microreactor Achieves Significant Breakthrough in Zero-Power High-Temperature Criticality Test
Westinghouse Electric Company recently announced that its eVinci microreactor achieved a significant breakthrough in a zero-power high-temperature criticality test, successfully achieving criticality at a temperature of 663 degrees Celsius, marking an important milestone in the project's development. This test is an important practice of the build-test-learn development model, providing key data for accelerating subsequent prototype design. The test was conducted at the U.S. Department of Energy National Nuclear Security Administration (NNSA)'s National Criticality Experiments Research Center (NCERC) in Nevada, with active cooperation and support from Los Alamos National Laboratory and the Nevada National Security Site (NNSS). The selection of the test site has sign...
2026-09-16
Hualong One Version 2.0 Independent Innovation Achievements Presented in Beijing
On September 11, the "Road of Independent Innovation for Hualong One" media tour was launched in Beijing, focusing on presenting the independent innovation achievements and technical advantages of Hualong One Version 2.0. According to reports, Hualong One Version 2.0 adopts Chinese standards and has the capability for 100% domestic production of key equipment, with its safety performance indicators ranking in the first tier among large pressurized water reactors globally. Hualong One is a million-kilowatt-class Generation III pressurized water reactor nuclear power technology developed on the basis of China's more than 40 years of experience in nuclear power research and development, design, manufacturing, construction, and operation, and possesses fully independent intellectual property rights. Hualong One Version 2.0, building on the summary of engineering construction and operational experience of Hualong One, has been launched through independent innovation and overall coordination...
2026-09-12